Dr. Sabine Sydow

Dr. Sabine Sydow joined OXB in September 2023 as Vice President, Corporate Strategy and Organisational Effectiveness and became Chief of Staff in April 2024. She has over 25 years of experience in the pharmaceutical and biotech industry. Dr. Sydow was previously at Rentschler Biopharma as Chief of Staff. Prior to this, she was head of vfa bio which represented the biotech interests within the German Association of Research-Based Pharmaceutical Companies (vfa), and she was also in various management positions at Schering AG in Berlin. Dr. Sydow studied biology at the Technical University Braunschweig and the Georg-August-University Göttingen and received her PhD at the Max-Planck-Institute for Experimental Medicine in Göttingen in the area of molecular neuroendocrinology where she also conducted post-doctoral research.